Dapagliflozin: Beneficial Effects Beyond Glycaemia

  • Nikolaos Papanas Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece
  • Djordje S. Popovic
DOI: https://doi.org/10.61797/ijdm.v1i1.63
Keywords: Dapagliflozin, Chronic Heart Failure, Chronic Kidney Disease

Abstract

-

Published
2021-08-16
Issue
Vol 1 No 1 (2021): Int J Diabetes Manag
Section
Articles

Copyright (c) 2021 Nikolaos Papanas, Djordje S. Popovic

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright © by the authors; licensee Research Lake International Inc., Canada. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creative-commons.org/licenses/by-nc/4.0/).